Research

UK College of Pharmacy Awarded $1.5 Million Grant to Accelerate Chemistry and Drug Discovery

Sylvie Garneau-Tsodikova and Vivek Subramanian in the UK PharmNMR Center.
Sylvie Garneau-Tsodikova, a professor in UK College of Pharmacy's Department of Pharmaceutical Sciences and principal investigator on the grant, works with Vivek Subramanian, director of the UK PharmNMR Center.

LEXINGTON, KY (Oct. 22, 2020) — The University of Kentucky College of Pharmacy was recently awarded a prestigious National Institutes of Health (NIH) High-End Instrumentation (HEI) grant to support the purchase of a state-of-the-art nuclear magnetic resonance (NMR) spectrometer, an instrument critical to supporting chemistry efforts at UK. Sylvie Garneau-Tsodikova, professor in the College of Pharmacy's Department of Pharmaceutical Sciences, is the principal investigator on the grant.

The grant is a culmination of a strategic effort to sustain and expand essential chemistry infrastructure in the UK PharmNMR Center. The funds will support the purchase of a new Bruker AVANCE NEO 600 MHz NMR spectrometer with CryoProbe. Additional key contributors to the grant include the center's director, Vivek Subramanian, and a cadre of federally-funded user group projects based in UK's Colleges of Pharmacy, Medicine and Arts & Sciences.

Under Garneau-Tsodikova's leadership, UKCOP is working with others on campus toward a model for consolidating NMR resources on campus to improve capabilities and efficiencies for all UK researchers. As part of this effort, UKCOP has made substantive strategic investments in the PharmNMR Center.

"We need stronger and more united NMR capabilities at UK and securing funding for this new state-of-the-art NMR instrument is a first step toward achieving this important goal," Garneau-Tsodikova said.

The new spectrometer will enable UK PharmNMR users to rapidly determine three-dimensional structures of small organic molecules and natural products, observe chemical and enzyme-catalyzed reactions in real time, and view drug-target interactions on a molecular level.

"The NMR is an indispensable tool in chemistry and biology. A significant amount of biological research at UK, including the Colleges of Pharmacy and Medicine, the Biomedical Biological Sciences Research Building, and the Chemistry department use NMR to focus on the structure of proteins, interaction between them, and protein-ligand interactions for drug development to cure diseases," Subramanian said

“The acquisition of this new instrument will allow us all to push our research projects in directions that were previously impossible here at UK,” said Nishad Thamban Chandrika, a research scientist at the college of pharmacy.

In addition to accelerating the translational objectives of UKCOP’s campus partners such as Markey Cancer Center, the Center for Clinical & Translational Science, and the recently funded COBRE for Pharmaceutical Research and Innovation, the new instrument will also support the research and training of the next generation of scientists.

R. Kip Guy, dean of the College of Pharmacy, views this award as an essential step in building the chemistry infrastructure needed for UK-based drug discovery and chemical biology research.

"This award allows us to significantly upgrade our NMR capacity and capabilities in order to support innovative science while increasing our ability to collaborate with others across UK's campus," he said. "I'm extremely proud of our team for all of the work that went into this application that provides for a much-needed addition to the UK PharmNMR Center and our campus research community."

Research reported in this publication was supported by the National Institute of General Medical Sciences under Award Number S10OD028690. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.

The University of Kentucky is increasingly the first choice for students, faculty and staff to pursue their passions and their professional goals. In the last two years, Forbes has named UK among the best employers for diversity, and INSIGHT into Diversity recognized us as a Diversity Champion three years running. UK is ranked among the top 30 campuses in the nation for LGBTQ* inclusion and safety. UK has been judged a “Great College to Work for" three years in a row, and UK is among only 22 universities in the country on Forbes' list of "America's Best Employers."  We are ranked among the top 10 percent of public institutions for research expenditures — a tangible symbol of our breadth and depth as a university focused on discovery that changes lives and communities. And our patients know and appreciate the fact that UK HealthCare has been named the state’s top hospital for four straight years. Accolades and honors are great. But they are more important for what they represent: the idea that creating a community of belonging and commitment to excellence is how we honor our mission to be not simply the University of Kentucky, but the University for Kentucky.